Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Baricitinib may effectively treat oral lichen planus.

Akt2 protein is essential for normal cell division in early mouse embryos.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

JAK inhibitors may reduce depression in people with alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

JAK inhibitors show promise for treating skin diseases effectively and safely.

CS12192 effectively treats alopecia areata with better safety than current options.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

The drug combination was safe and showed promise in treating advanced tumors.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Ruxolitinib can help regrow hair in severe alopecia areata.

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.